Monopar TherapeuticsMNPR
Monopar Therapeutics — a healthcare name on Nasdaq.
Monopar Therapeutics — ticker MNPR — is a healthcare company listed on Nasdaq operating in pharmaceutical preparations.
A descriptive overview for MNPR is pending the next reference-data sync.
MNPR on the desk: alerts, trims, and member tracking.
Below is the outcome history for MNPR from Sensei's alert feed. Entry, target, and stop levels — plus the chart-level reasoning — are members-only.
- BUYSep 12, 2024Hit+7.14%
- BUYSep 12, 2024Hit+14.00%
- BUYFeb 23, 2024Hit+28.15%
- BUYFeb 23, 2024Hit+11.11%
- BUYFeb 22, 2024Hit+37.00%
- BUYFeb 22, 2024Hit+10.00%
- BUYFeb 22, 2024Hit+7.00%
- BUYFeb 22, 2024Hit+22.99%
- BUYFeb 20, 2024Hit+48.57%
- BUYNov 1, 2023Hit+10.42%
Full details unlock inside the app
Common questions about this stock.
What is MNPR?
MNPR is the trading symbol for Monopar Therapeutics, listed on Nasdaq in the healthcare sector.
What sector is MNPR in?
Monopar Therapeutics (MNPR) is classified in the healthcare sector — specifically pharmaceutical preparations, based on its SEC SIC classification.
Has Sensei traded MNPR?
Yes — MNPR has appeared in the Sensei alert feed 10 times, including 10 calls that hit target. The "Sensei's calls on MNPR" section above lists the recent history; entry, target, and stop levels are members-only.
Where does MNPR trade?
MNPR trades on Nasdaq.
Is MNPR a stock or an ETF?
MNPR is a publicly-traded common stock, not an ETF.
Trade MNPR alongside Sensei.
Live alerts, a focused community, and the full course library. $60/month. Cancel anytime.